Why the study?
Is traditional antihypertensive treatment more cost-effective than current treatment in patients with hypertension?
Population
Patients with grade 1 or 2 hypertension (HT1-2) and grade 3 hypertension (HT3)
Comparison
Current treatment vs Traditional treatment
Follow-up
12 months
Authors
Loading...
May support traditional agents for cost-effectiveness in milder hypertension; hypothesis-generating and requires randomized confirmation before practice change.
Is traditional antihypertensive treatment more cost-effective than current treatment in patients with hypertension?
Traditional antihypertensive therapy (hydrochlorothiazide and atenolol) is more cost-effective than newer therapy (losartan and amlodipine) for grade 1-2 hypertension, with no difference in cost-effectiveness for grade 3 hypertension.
Tsuji et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: